Skip to content

Clinical and immunological features of autoimmune encephalitis: a single-center observational study

Clinical and immunological features of autoimmune encephalitis: a single-center observational study

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000029115
Enrollment
Unknown
Registered
2020-01-14
Start date
2019-09-01
Completion date
Unknown
Last updated
2020-01-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Autoimmune encephalitis

Interventions

Autoimmune encephalitis:None

Sponsors

Huashan Hospital, Fudan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18 and 80 years old; 2. Be able to understand and sign informed consent; 3. Meet the diagnostic criteria agreed by Chinese experts in the diagnosis and treatment of autoimmune encephalitis: (1) Subacute onset (rapid progression of less than 3 months) of the following symptoms: 1) One or more symptoms suggested of limbic system involvement: short-term memory loss, seizures, and psychiatric symptoms; 2) Syndromes of encephalitis: clinical presentations of diffuse or multiple lesions of central nervous system; 3) clinical presentations of basal ganglia and / or diencephalon / hypothalamus involvement; 4) Nonorganic mental disorders. (2) At least one of the following, or combined with tumor: 1) CSF pleocytosis (white blood cell count of more than five cells per mm3), or lymphocytic inflammation in CSF, or positive oligoclonal bands; 2) Neuroimaging or electrophysiological abnormalities: abnormal brain MRI or PET, or abnormal electroencephalogram. 3) Discovery of tumor related to autoimmune encephalitis; (3) Definite diagnosis: positive neural cell-surface antibodies; (4) Reasonable exclusion of alternative causes. Possible autoimmune encephalitis should meet: (1), (2), (4). Definite autoimmune encephalitis should meet: (1), (2), ?, 4. In clinical practice, there exist autoantibody-negative autoimmune encephalitis. Therefore, patients meet the diagnostic criteria of possible autoimmune encephalitis were included in this study.

Exclusion criteria

Exclusion criteria: 1. Patients with pregnancy; 2. Patients who have participated in other clinical trials in recent 3 months.

Design outcomes

Primary

MeasureTime frame
mRS;

Countries

China

Contacts

Public ContactChen Xiangjun

Huashan Hospital, Fudan University

xiangjchen@fudan.edu.cn+86 02125888159

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 16, 2026